| Literature DB >> 34703363 |
Mohammad K Parvez1, Mohammed S Al-Dosari1, Md Tabish Rehman1, Mohammed F Alajmi1, Ali S Alqahtani1,2, Mansour S AlSaid1,2.
Abstract
Elevation in hyperglycemia-associated methylglyoxal level can trigger vascular endothelial cells oxidative stress and apoptosis. The present work assesses the cell proliferative, anti-oxidative and anti-apoptotic potential of Suaeda monoica derived four new terpenes: a norsesquaterpenol (normonisesquaterpenol), a monocyclic triterpenoid (suaedanortriterpene dione), an aromatic monoterpenic ester and a labdane-type norditerpenic xyloside as well as two new phenols: an alkylated β-naphthol and a β-methoxy naphthalene in cultured human umbilical vein endothelial cells (HUVEC). Of these, suaedanortriterpenedione (53.7%), normonisesquaterpenol (51.4%) and norditerpenic xyloside (48%) showed the most promising cell proliferative activities compared to others. Moreover, normonisesquaterpenol, norditerpenic xyloside and suaedanortriterpenedione efficiently reversed the oxidative and apoptotic cell damage via downregulation of capase-3/7 by 44.3%, 42.2% and 39.4%, respectively against dichlorofluorescin, whereas by 46.2%, 43.5% and 42.5%, respectively against methylglyoxal. Aminoguanidine, the reference drug inhibited caspase-3/7 activity by 56.2% and 54.7% through attenuation of dichlorofluorescin and methylglyoxal, respectively. Further in silico molecular docking analysis revealed formation of stable complexes between the tested compounds and caspase-3/7. Conclusively, we for the first time demonstrate the growth stimulatory, anti-oxidative and anti-apoptotic salutations of S. monoica derived novel compounds in human endothelial cells. This warrants their further assessment as vascular cell protective and rejuvenating therapeutics, especially in hyperglycemic conditions.Entities:
Keywords: Apoptosis; Dichlorofluorescin; Endothelial cells; Methylglyoxal; Suaeda monoica; Terpenes
Year: 2021 PMID: 34703363 PMCID: PMC8523353 DOI: 10.1016/j.jsps.2021.08.007
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Fig. 1Chemical structure of Suaeda monoica derived new terpenic and phenolic compounds: normonisesquaterpenol, suaedanortriterpenedione, aromatic monoterpenic ester, norditerpenic xyloside, alkylated β-naphthol and β-methoxy naphthalene.
Fig. 2Cell proliferative (MTT) assay showing dose-dependent growth stimulatory activity of Suaeda monoica derived new compounds (12.5, 25 and 50 μg/ml): norsesquaterpenol (NSQ), suaedanortriterpenedione (SND), aromatic monoterpenic ester (AES), norditerpenic xyloside (NDX), alkylated β-naphthol (ABN) and β-methoxy naphthalene (BMN) in cultured human endothelial cells (HUVEC). UT: un-treated. Values on Y-axis: means of three determinations. All samples in triplicate were test-repeated twice.
Fig. 3Cell proliferative (MTT) assay showing cytoprotective activity of Suaeda monoica derived new compounds (25 and 50 μg/ml): norsesquaterpenol (NSQ), suaedanortriterpenedione (SND), aromatic monoterpenic ester (AES), norditerpenic xyloside (NDX), alkylated β-naphthol (ABN) and β-methoxy naphthalene (BMN) against dichlorofluorescin (DCF; 32.5 ug/ml) induced oxidative stress in cultured human endothelial cells (HUVEC). DMSO: vehicle control; UT: un-treated control. Values on Y-axis: means of three determinations. All samples in triplicate were test-repeated twice.
Fig. 4Cell proliferative (MTT) assay showing cytoprotective activity of Suaeda monoica derived new compounds (25 and 50 μg/ml): norsesquaterpenol (NSQ), suaedanortriterpenedione (SND), aromatic monoterpenic ester (AES), norditerpenic xyloside (NDX), alkylated β-naphthol (ABN) and β-methoxy naphthalene (BMN) against Methylglyoxal (MGO; 0.05 mM) triggered apoptosis in cultured human endothelial cells (HUVEC). DMSO: vehicle control; UT: un-treated control. Values on Y-axis: means of three determinations. All samples in triplicate were test-repeated twice.
Fig. 5The anti-apoptotic assay showing inhibition of dichlorofluorescin (DCF; 32.5 μg/ml) and methylglyoxal (MGO; 0.05 mM) induced cellular caspase-3/7 expressions by Suaeda monoica derived new compounds (25 μg/ml): suaedanortriterpenedione (SND), norsesquaterpenol (NSQ) and norditerpenic xyloside (NDX) in cultured human endothelial cells (HUVEC). DMSO: vehicle control; UT: un-treated control. Values on Y-axis: means of three determinations. All samples in triplicate were test-repeated twice.
Fig. 6The in silico molecular docking analysis showing interaction of caspase-3 with Suaeda monoica derived compounds. Panel I: (A) all compounds, (B) ligand control TQ8, (C) Alkylated β-naphthol, (D) Aromatic monoterpenic; Panel II: (A) β-methoxy naphthalene, (B) Norditerpenic xyloside, (C) Norsesquaterpenol, (D) Suaedanortriterpenedione.
Molecular docking analysis of complexes formed by S. monoica derived compounds with caspase-3 and caspase-7.
| Ligand control* | −5.8 | 1.79 × 104 | −9.6 | 1.10 × 107 |
| Norsesquaterpenol | −7.4 | 2.68 × 105 | −8.0 | 7.37 × 105 |
| Suaedanortriterpenedione | −5.5 | 1.08 × 104 | −6.2 | 3.53 × 104 |
| Aromatic monoterpenic ester | −5.5 | 1.08 × 104 | −5.7 | 1.52 × 104 |
| Norditerpenic xyloside | −6.6 | 6.93 × 104 | −7.6 | 3.75 × 105 |
| Alkylated β-naphthol | −6.1 | 2.98 × 104 | −6.6 | 6.93 × 104 |
| β-methoxy naphthalene | −5.8 | 1.79 × 104 | −6.3 | 4.18 × 104 |
*Ligand controls: TQ8 (N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide) for caspase- 3 and Acetyl-YVAD-CHO for caspase-7.
Molecular docking parameters for the interaction between caspase-3 and S. monoica derived compounds.
| Control* | ARG207:HN - LIG:O | 1.8753 | Conventional Hydrogen Bond | SER65, TYR204, SER205, ASN208, SER209, PHE250 |
| ABN | ARG207:HE - LIG:O | 2.4690 | Conventional Hydrogen Bond | TYR204, SER205, TRP206, PHE252, ASP253 |
| AES | HIS121:HD1 - LIG:O | 2.3773 | Conventional Hydrogen Bond | THR62, GLY122, GLY165, THR166 |
| BMN | TYR204:HH - LIG:O | 2.0032 | Conventional Hydrogen Bond | ASP253 |
| NDX | ARG207:HH22 - LIG:O | 2.3814 | Conventional Hydrogen Bond | GLY122, THR166, SER205 |
| NSQ | LIG:C - PHE256 | 3.5475 | Hydrophobic (Pi-Sigma) | TYR204, TRP206, ARG207, ASN208, SER209, LYS210, PHE250, SER251, ASP253 |
| SND | SER209:HN - LIG:O | 2.2032 | Conventional Hydrogen Bond | TYR204, ASN208, SER251 |
*Chemically the control TQ8 is N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide.
Fig. 7The in silico molecular docking analysis showing interaction of caspase-7 with Suaeda monoica derived compounds. Panel I: (A) all compounds, (B) ligand control Acetyl-YVAD-CHO, (C) Alkylated β-naphthol, (D) Aromatic monoterpenic; Panel II: (A) β-methoxy naphthalene, (B) Norditerpenic xyloside, (C) Norsesquaterpenol, (D) Suaedanortriterpenedione.
Molecular docking parameters for the interaction between caspase-7 and S. monoica derived compounds.
| Control* | ARG233:HN - LIG:O | 2.0867 | Conventional Hydrogen Bond | SER231, TRP232, SER234, PRO235, ARG237, TRP240, PHE273, GLU274, SER275, SER277, PHE282 |
| ABN | ARG87:HE - LIG:O | 2.3632 | Conventional Hydrogen Bond | SER143, GLY145, GLN184, ALA185, CYS186, SER231, TRP232, SER277, PHE282 |
| AES | CYS186:SG - LIG:O | 3.5904 | Conventional Hydrogen Bond | SER231, ARG233, SER277, PHE282 |
| BMN | HIS144:CE1 - LIG:O | 3.6982 | Carbon Hydrogen Bond | MET84, SER231, ARG233, SER277, PHE282 |
| NDX | TRP240:HE1 - LIG:O | 2.1034 | Conventional Hydrogen Bond | SER231, ARG233, SER234, ARG237, SER275, SER277 |
| NSQ | LIG:H - GLN276:O | 1.7762 | Conventional Hydrogen Bond | VAL86, ARG233, SER234, ARG237, GLU274, SER275, SER277 |
| SND | CYS186:SG - LIG:O | 3.2926 | Conventional Hydrogen Bond | SER231, SER275, GLN276, SER277 |
* The chemical nature of Caspase 7 control ligand (peptide based inhibitor) is Acetyl-YVAD-CHO.